CANNAHEALTH An Overview of Cannabis | Page 48

48

1. Pertwee RG, ed. Handbook of Cannabis. Oxford. U.K.: Oxford University Press;2014

2. Guy GW, Whittle BA, Robson PJ, eds. The Medicinal Uses of Cannabis and Cannabinoids. London, U.K.: Pharmaceutical Press;2004.

3. Grotenhermen F, Russo E, eds. Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential. New York, NY: The Haworth Therapeutic Press; 2002.

4. Devinsky O, Cohen LR, Selig R. Weed: marijuana, medicine, and neuroscience. History of the Alfred I. Dupont-Columbia University Award. Neurosurgery 2015; 76:357-61.

5. Maida V, and Daeninck PJ. A user’s guide to cannabis therapies in oncology. Curr Oncol. 2016 Dec;23(6):398-406.

6. Lynch M, Campbell F. Cannabinoids for treatment of chronic, non-cancer pain: a systematic review of randomized trials. Brit J Clin Pharmacol 2011; 72:735-44.

7. Lynch M, Ware MA. Cannabinoids for the treatment of chronic non-cancer pain: an updated systematic review of randomized trials. J Neuroimmune Pharmacol 2015; 10:293-301.

8. Tramer MR, Carrol D, Campbell FA, Reynolds DJ, Moore RA, McQuay HJ. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ 2001; 323:16-21.

9. Machado Rocha FC, Stefano SC, De Cassia Haiek R, Rosa Oliveira LM, Da Silveira DX. Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis. Eur J Cancer Care (Engl) 2008; 17:431-43.

10. Haney M, Rabkin J, Gunderson E, Foltin RW. Dronabinol and marijuana in HIV+ marijuana smokers: acute effects on caloric intake and mood. Psychopharmacology (Berl) 2005; 181:170-8.

11. Volicer L, Stelly M, Morris J, McLaughlin J, Volicer BJ. Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer’s disease. Int J Geratr Psychiatry 1997; 12:913-19.

12. Reus GZ, Stringari RB, Ribeiro KF, et al. Administration of cannabidiol and imipramine induces antidepressant-like effects in the forced swimming test and increases brain-derived neurotrophic factor levels in the rat amygdala. Acta Neuropsychiatr 2011; 23:241-8.

13. Campos AC, Moreira FA, Gomes FV, Del Bel EA, Guimaraes FS. Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders. Philos Trans R Soc Lond B Biol Sci 2012; 367:3364-78.

14. Ward SJ, McAllister SD, Kawamura R, Murase R, Neelakantan H, Walker EA. Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT 1a receptors without diminishing nervous system functioning or chemotherapy efficacy. Br J Phamacol 2014; 171:636-45.

REFERENCES